Modulation of hepatic stellate cells by Mutaflor(®) probiotic in non-alcoholic fatty liver disease management

BACKGROUND: NAFLD and NASH are emerging as primary causes of chronic liver disease, indicating a need for an effective treatment. Mutaflor® probiotic, a microbial treatment of interest, was effective in sustaining remission in ulcerative colitis patients. OBJECTIVE: To construct a genetic-epigenetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hany, Noha M., Eissa, Sanaa, Basyouni, Manal, Hasanin, Amany H., Aboul-Ela, Yasmin M., Elmagd, Nagwa M. Abo, Montasser, Iman F., Ali, Mahmoud A., Skipp, Paul J., Matboli, Marwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338485/
https://www.ncbi.nlm.nih.gov/pubmed/35907883
http://dx.doi.org/10.1186/s12967-022-03543-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338485/
https://www.ncbi.nlm.nih.gov/pubmed/35907883
http://dx.doi.org/10.1186/s12967-022-03543-z

Ejemplares similares